| Device |
autoantibodies, glutamic acid decarboxylase (gad) |
| Regulation Description |
Multiple autoantibodies immunological test system. |
| Definition |
The device is used for the semi-quantitative determination of glutamic acid decarboxylase (GAD) autoantibodies in human serum as an aid in the diagnosis of Type I diabetes mellitus (autoimmune mediated diabetes). |
| Physical State |
Not applicable |
| Technical Method |
Immunoassay |
| Target Area |
Not applicable |
| Regulation Medical Specialty |
Immunology |
| Review Panel |
Immunology |
| Product Code | NWG |
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Immunology and Hematology Devices
(DIHD)
|
| Submission Type |
510(k)
|
| Regulation Number |
866.5660
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
|
Third Party Review
|
Accredited Persons
|